With the two positive trials, GSK plans to file Blenrep with the FDA in the second half of this year, Hesham Abdullah, M.D., ...

After Enhertu pioneered the HER2-low category in breast cancer treatment, AstraZeneca and Daiichi Sankyo are now hopeful that ...

When companies introduce an injectable version of an intravenously infused drug, better convenience with comparable efficacy ...

After Amgen’s KRAS confirmatory trial results were rejected by the FDA as uninterpretable, Bristol Myers Squibb has provided ...

Moderna's mRESVIA has secured FDA approval to protect adults ages 60 years and older from lower respiratory tract disease ...

While Canada’s largest vaccine manufacturing facility has opened its doors and is flying the Sanofi flag, another of the ...

In the span of half a year, Gilead’s Trodelvy has flopped a second phase 3 trial. | Following a high-profile lung cancer ...

Gilead Sciences is drawing back the curtain on the Trodelvy lung cancer data that previously caused a 10% slide in the ...

One of the biggest take-aways from our report is that LGBTQ+ people are probably at higher risk for cancer, yet experience ...

With a target date for FDA approval less than a month away, Sanofi and Regeneron’s megablockbuster Dupixent has gained much ...

As various efforts to produce next-generation vaccines in Africa are being carried forward by the likes of the World Health ...

While several CDMO giants have been weathering an industry slowdown in recent years following the pandemic and longing for ...